Health and Healthcare Systems
How could an existing liver disease drug help reduce COVID cases?
Ursodeoxycholic acid (UDCA), targets a receptor called ACE2, which is the ‘doorway’ that SARS-CoV-2 uses to infect cells. It could help us fight COVID-19.